Surgical robots are advanced medical systems designed to assist surgeons in performing complex procedures with greater precision, control, visualization, and consistency. These systems combine robotics, high-definition imaging, computer-assisted navigation, specialized surgical instruments, sensors, software, and increasingly artificial intelligence. In 2026, surgical robotics is being deployed across general surgery, urology, gynecology, orthopedics, neurosurgery, spinal procedures, oncology, and other minimally invasive surgical applications.
Unlike conventional surgical instruments, modern Surgical Robots can provide highly controlled instrument movement, motion scaling, tremor reduction, image-guided navigation, digital procedure planning, and advanced visualization. The global ecosystem includes established companies such as Intuitive Surgical, Stryker, Accuray, THINK Surgical, Renishaw, and Medrobotics, alongside technologies that have become part of larger organizations through acquisitions, including Mazor Robotics, TransEnterix/Asensus Surgical, Hansen Medical, and Verb Surgical.
What Are Surgical Robots Companies?
Surgical robots companies are medical-technology businesses that develop robotic surgical platforms, computer-assisted navigation systems, robotic instruments, surgical planning software, imaging technologies, accessories, services, or integrated operating-room solutions designed to support surgeons during medical procedures.
The competitive landscape in 2026 includes several technology categories. Intuitive Surgical is strongly associated with soft-tissue robotic-assisted surgery through the da Vinci ecosystem. Stryker participates prominently in orthopedic robotic surgery through the Mako platform. THINK Surgical focuses on orthopedic robotic technologies, while Renishaw has experience in precision-guided neurosurgical solutions. Accuray operates in robotically controlled radiation-delivery systems, while several historically significant surgical robotics companies have been acquired and integrated into larger medical-device organizations.
How Big Is the Surgical Robots Industry in 2026?
The global Surgical Robots industry was valued at USD 12.08 billion in 2025 and is projected to reach USD 14.33 billion in 2026. The industry is projected to expand further to USD 16.99 billion in 2027 and reach approximately USD 66.46 billion by 2035, representing a CAGR of 18.59% from 2026 to 2035.
Expansion is being supported by rising adoption of minimally invasive procedures, growing surgical volumes, increasing demand for precision-based treatment, improvements in visualization, and broader use of robotics across general surgery, orthopedics, urology, gynecology, neurosurgery, and spinal procedures. Hospitals are also increasingly evaluating robotic systems as part of wider digital operating-room strategies.
The industry is moving beyond mechanically assisted surgery toward connected platforms combining robotics, imaging, navigation, data analytics, artificial intelligence, digital procedure planning, and automated workflow support. Accessories and recurring service requirements also create an ongoing commercial ecosystem around installed robotic systems.
Global Distribution of Surgical Robots Manufacturers by Country in 2026
Surgical robotics development is concentrated in countries with established medical-device industries, advanced hospitals, substantial healthcare expenditure, strong engineering capabilities, and supportive research environments. The United States remains one of the principal development centers, with Intuitive Surgical, Stryker, Accuray, THINK Surgical, and several historically important robotics businesses originating or operating extensively in the country.
The United Kingdom contributes through precision-engineering and medical-technology businesses such as Renishaw. Israel has played an important role in robotic and navigation technologies, including the development of Mazor Robotics before its acquisition by Medtronic.
Germany has become increasingly relevant through companies and medical-technology groups supporting robotic surgery, endoscopy, imaging, and operating-room technologies. KARL STORZ strengthened its surgical robotics activities through its acquisition of Asensus Surgical in 2024.
Asia-Pacific is also expanding rapidly. China, Japan, South Korea, India, and Singapore are seeing growing investment in robotic surgery, advanced hospitals, domestic medical-device manufacturing, digital healthcare, and minimally invasive procedure capacity.
Growing Across Major Regions and Opportunities
Geographic expansion of surgical robotics is being driven by rising demand for minimally invasive procedures, increasing hospital investment, aging populations, expansion of specialty surgical centers, and growing interest in technologies that can improve consistency and visualization during complicated procedures.
Opportunities vary significantly by region. Mature healthcare systems are increasingly replacing or expanding existing robotic fleets, while developing Industrys often represent first-time installations. This creates opportunities not only for robotic-system manufacturers but also for companies supplying instruments, maintenance, imaging, training, navigation software, procedure-planning systems, and operating-room integration.
North America: Key Countries and Statistics
North America is a major Surgical Robots development and commercialization region, led by the United States. The region benefits from high healthcare expenditure, large surgical volumes, advanced hospital infrastructure, strong medical-device research capabilities, and an established ecosystem of surgeons trained in robotic-assisted procedures.
North America accounts for approximately 42% of the global Surgical Robots Industry. U.S.-based or U.S.-centered businesses such as Intuitive Surgical, Stryker, Accuray, and THINK Surgical contribute to the region's extensive technology base.
The next phase of growth in North America is increasingly focused on expanded indications, multi-specialty robotic platforms, outpatient surgery, improved imaging, smaller system footprints, digital workflow integration, and greater use of software and artificial intelligence.
Europe: Key Countries and Statistics
Europe represents approximately 28% of the global Surgical Robots Industry, supported by advanced healthcare systems in Germany, the United Kingdom, France, Italy, Switzerland, Spain, and the Nordic countries. European hospitals have steadily increased adoption of robotic-assisted procedures across urology, gynecology, general surgery, neurosurgery, orthopedics, and other specialties.
The United Kingdom contributes through precision-engineering companies such as Renishaw, while Germany has a substantial medical-device and surgical-technology ecosystem. Europe is also home to a growing group of newer robotic-surgery developers specializing in compact platforms, minimally invasive surgery, microsurgery, and digital operating-room technologies.
Regulatory compliance, clinical evidence, cost effectiveness, surgeon training, equipment utilization, and reimbursement remain important factors influencing procurement decisions across European healthcare systems.
Asia-Pacific: Key Countries and Statistics
Asia-Pacific accounts for approximately 22% of the global Surgical Robots Industry and represents a major long-term expansion opportunity. China, Japan, South Korea, India, Australia, and Southeast Asian countries are increasing investment in hospital infrastructure and high-technology surgical equipment.
China is developing domestic robotic-surgery capabilities while continuing to represent an important Industry for international manufacturers. Japan has strong expertise in precision engineering, medical devices, imaging, and robotics. South Korea combines advanced hospitals with substantial technology investment, while India's large patient population and expanding private healthcare sector are creating additional demand.
Opportunities across Asia-Pacific include lower-cost systems, compact robotic platforms, locally manufactured surgical instruments, surgeon-training infrastructure, specialty hospitals, orthopedic robotics, and technologies designed for high-volume healthcare environments.
Middle East & Africa: Key Countries and Statistics
The Middle East & Africa account for approximately 8% of the global Surgical Robots Industry. Adoption remains concentrated in advanced medical centers and countries investing heavily in healthcare modernization, including Saudi Arabia, the United Arab Emirates, Israel, Qatar, and South Africa.
Gulf countries are investing in specialist hospitals, healthcare tourism, advanced surgical centers, and digital health infrastructure. These investments provide opportunities for premium robotic systems as well as surgeon-training, maintenance, software, instruments, and clinical-support services.
Africa remains an earlier-stage Industry because high equipment costs, limited specialist training, infrastructure requirements, and restricted healthcare budgets can constrain adoption. However, major urban hospitals and specialist healthcare groups offer longer-term opportunities as advanced surgical infrastructure expands.
Companies Update
The competitive landscape combines active independent surgical-technology companies with several historically important robotic businesses that are now subsidiaries, acquired technologies, or legacy brands. Revenue figures below refer to total company revenue where surgical-robotics-specific revenue is not reported separately.
| Company | Headquarters / Origin | Latest Reported Annual Revenue / Status | Geographic Presence | Key Highlight | Holding Type |
|---|---|---|---|---|---|
| Accuray | Madison, Wisconsin, U.S. | Fiscal 2025 net revenue: approximately USD 458.5 million | Global | Robotically controlled radiation-treatment technologies including CyberKnife | Public |
| Britannica | Company identity requires verification | Listed within the supplied Surgical Robots company profile set; standalone surgical-robotics financial information is not clearly disclosed | Not independently established | Company name should be verified before financial or product-level attribution | - |
| MAKO / Stryker Corporation | Portage, Michigan, U.S. | Stryker FY2025 net sales: approximately USD 25.1 billion | Global | Mako robotic-arm assisted surgery for orthopedic procedures | Public; Mako technology within Stryker |
| TransEnterix / Asensus Surgical | United States | No longer an independent public company following acquisition | International technology footprint | Developed digital and robotic technologies including Senhance; Asensus was acquired by KARL STORZ in 2024 | KARL STORZ subsidiary/business |
| THINK Surgical, Inc. | Fremont, California, U.S. | Private company; annual revenue not publicly disclosed | U.S. and selected international Industrys | Orthopedic robotics and personalized surgical-planning technologies | Private |
| Medrobotics | Massachusetts, U.S. | Private-company financial information not routinely disclosed | Selected international Industrys | Flexible robotic technologies designed to provide access to difficult anatomical locations | Private / corporate status should be checked against latest filings |
| Mazor Robotics | Israel | Revenue no longer separately reported as an independent company | Technology integrated into Medtronic's surgical portfolio | Historically important robotic guidance technology for spine surgery | Acquired by Medtronic |
| Intuitive Surgical | Sunnyvale, California, U.S. | FY2025 revenue: approximately USD 10.06 billion | Global | da Vinci surgical systems and Ion endoluminal platform | Public |
| Renishaw plc | Wotton-under-Edge, United Kingdom | FY2025 group revenue: approximately GBP 713.0 million | Global | Precision measurement, neurosurgical robotics and image-guided technologies | Public |
| Hansen Medical | California, U.S. | Revenue no longer separately disclosed as an independent company | Legacy robotic technology incorporated through subsequent ownership | Historically developed robotic catheter technologies | Legacy/acquired business |
| Verb Surgical | California, U.S. | Revenue not separately reported | Technology integrated into Johnson & Johnson's broader digital-surgery strategy | Created as a surgical robotics collaboration before Johnson & Johnson acquired the remaining stake | Johnson & Johnson-owned legacy technology/business |
Latest Company Updates in 2026
Intuitive Surgical continues expanding its robotic surgery ecosystem around the da Vinci platform. The company reported approximately USD 10.06 billion in revenue for 2025, representing substantial growth from the prior year. Approximately 3.15 million procedures were performed using da Vinci systems during 2025, demonstrating the scale of its installed ecosystem and recurring instrument demand.
Stryker continues strengthening Mako as an important component of its orthopedic technology portfolio. The company generated approximately USD 25.1 billion in total net sales during 2025. Its strategy combines robotic assistance with implants, surgical planning, digital technologies, and orthopedic workflows.
Accuray remains focused on precision radiation-treatment technologies. Its CyberKnife platform uses robotic movement and image guidance to deliver radiation treatments, positioning the company at the intersection of robotics, oncology, imaging, and precision therapy.
THINK Surgical continues focusing on orthopedic robotic solutions, particularly technologies supporting personalized planning and robot-assisted knee procedures. Orthopedics remains one of the most competitive segments within surgical robotics because implant manufacturers and independent robotics developers are investing heavily in digitally assisted surgery.
TransEnterix represents the earlier corporate identity associated with what became Asensus Surgical. Asensus Surgical was acquired by KARL STORZ in 2024, meaning the technology is no longer operated as an independent publicly traded surgical-robotics company. The acquisition gives KARL STORZ an expanded platform for developing surgical robotics and digitally assisted operating-room technologies.
Mazor Robotics remains historically important to spine robotics, although it is no longer an independent company. Medtronic completed its acquisition of Mazor Robotics in 2018 and subsequently integrated robotic guidance technology into its broader spine and enabling-technologies strategy.
Renishaw continues operating across precision engineering, measurement, manufacturing technologies, and medical applications. Its expertise in high-accuracy positioning and image-guided systems provides technological relevance to neurosurgical and precision medical applications.
Hansen Medical is best viewed as a legacy robotic technology company rather than an independent 2026 competitor. Its historical work centered on robotically controlled catheter systems for intravascular procedures, and its technologies subsequently became part of larger corporate structures.
Verb Surgical is similarly a legacy name within the modern competitive landscape. Johnson & Johnson acquired the remaining stake in Verb Surgical following its earlier collaboration with Verily, incorporating the company's robotics and digital-surgery capabilities into a broader medical-technology strategy.
Medrobotics has been associated with flexible robotic systems designed to enable surgeons to reach difficult anatomical locations through minimally invasive approaches. Flexible and miniaturized robotic technologies remain an important area of innovation as developers seek to expand robotic surgery into new specialties.
High-End and Specialty Surgical Robots Manufacturers
The premium end of surgical robotics is increasingly defined by integrated systems combining advanced instrumentation, high-resolution imaging, surgical planning, digital workflow management, data collection, artificial intelligence, and specialized accessories.
Intuitive Surgical competes through a broad installed ecosystem of robotic systems, instruments, services, software, and surgeon experience. Stryker differentiates through the combination of Mako robotics with orthopedic implants and surgical-planning workflows. THINK Surgical concentrates on orthopedic applications, while Renishaw's engineering capabilities support highly precise image-guided medical applications.
Specialty opportunities also exist outside conventional laparoscopic surgery. Robotic systems are increasingly being developed for spine surgery, neurosurgery, orthopedics, bronchoscopy, microsurgery, vascular interventions, natural-orifice procedures, and other highly specialized clinical applications.
Competition is therefore shifting beyond basic robotic movement. Manufacturers increasingly compete on clinical evidence, procedure coverage, instrument availability, system footprint, surgeon ergonomics, imaging quality, installation requirements, maintenance costs, procedure economics, interoperability, and software capabilities.
Opportunities for Startups & Emerging Players in 2026
Startups have substantial opportunities because the Surgical Robots industry is expanding into clinical areas where existing platforms do not yet dominate. Rather than attempting to reproduce broad multi-specialty systems, emerging companies can focus on specific procedures, specialties, or workflow problems.
Orthopedic robotics remains attractive because hospitals increasingly combine preoperative imaging, implant planning, navigation, robotic cutting or positioning, and postoperative data. Smaller and more modular orthopedic systems may provide alternatives for hospitals that cannot justify large capital investments.
Microsurgery is another developing opportunity. Highly precise robotic platforms can potentially assist procedures involving small blood vessels, nerves, ophthalmic structures, and other anatomy requiring very controlled movements.
Flexible robotics also offers significant potential. Smaller robotic instruments capable of navigating natural openings or narrow anatomical pathways could expand minimally invasive treatment in pulmonology, urology, gastroenterology, ENT, and other clinical specialties.
Artificial intelligence represents another major innovation area. AI can support anatomical recognition, procedure planning, imaging analysis, workflow guidance, instrument tracking, training, and predictive maintenance. The commercial opportunity is therefore broader than manufacturing a complete surgical robot.
Startups can also develop enabling technologies such as force sensing, haptic feedback, navigation software, compact actuators, surgical simulation, training platforms, digital twins, image processing, robotic instruments, sterilizable components, workflow analytics, and interoperability software.
Key Growth Drivers for Surgical Robots in 2026
Demand for minimally invasive surgery remains one of the strongest growth drivers. Smaller incisions, improved visualization, precise instrument movement, and potentially shorter recovery periods are encouraging hospitals and surgical teams to evaluate robot-assisted procedures across a growing range of specialties.
Artificial intelligence and advanced imaging are also changing system design. More than 61% of newly introduced robotic products are associated with AI or advanced three-dimensional imaging features, reflecting the industry's transition toward data-driven surgical support.
Hospital adoption is expanding beyond the largest academic medical centers. Mid-sized hospitals and specialty surgical organizations increasingly evaluate robotics as systems become more versatile and competition expands. This trend creates opportunities for manufacturers offering lower capital costs, leasing arrangements, service models, and platforms capable of supporting multiple procedure categories.
Challenges Facing Surgical Robots Companies
High acquisition and operating costs remain significant barriers. Hospitals must consider not only the purchase price of a robot but also instruments, service agreements, training, operating-room modifications, utilization rates, procedure volumes, and replacement cycles.
Training is another important issue. Approximately 59% of hospitals identify shortages of appropriately trained professionals as a challenge affecting robotic surgery adoption. Manufacturers therefore increasingly provide simulation, surgeon education, technical support, and structured training programs alongside their systems.
Regulatory approval can also lengthen commercialization timelines because robotic medical devices must demonstrate safety and performance across individual procedures and Industrys. New companies require substantial capital for engineering, quality systems, clinical evaluation, regulatory submissions, manufacturing scale-up, and post-Industry support.
Future of Surgical Robotics
The future of surgical robotics is moving toward smaller platforms, broader procedure coverage, more sophisticated imaging, greater software integration, and increased automation of selected workflow steps. Artificial intelligence is expected to play a larger role in planning, anatomical identification, procedure guidance, training, and clinical-data analysis.
Competition may also increase as more manufacturers enter specialties that have historically been dominated by a small number of robotic systems. Greater competition could encourage new purchasing models, more interoperable instruments, reduced system footprints, and technologies designed for ambulatory surgical centers and regional hospitals.
Remote collaboration is another developing area. Fully autonomous remote surgery faces substantial technical, regulatory, network, liability, and clinical challenges, but robotic platforms can increasingly support remote mentoring, digital collaboration, procedure review, and specialist consultation.
Conclusion
The Surgical Robots industry in 2026 is evolving from specialized robotic assistance into a broader digital surgery ecosystem. The global sector, valued at USD 12.08 billion in 2025, is projected to rise from USD 14.33 billion in 2026 to USD 66.46 billion by 2035, representing a CAGR of 18.59% during the projected period.
North America remains the largest regional Industry with approximately 42% share, followed by Europe at 28%, Asia-Pacific at 22%, and the Middle East & Africa at 8%. Growth is being supported by minimally invasive procedures, expanding hospital adoption, improvements in imaging and navigation, surgeon demand for precision tools, and the integration of artificial intelligence into surgical workflows.
The competitive environment includes active companies such as Intuitive Surgical, Stryker, Accuray, THINK Surgical, Renishaw, and Medrobotics as well as historically influential technologies from TransEnterix/Asensus Surgical, Mazor Robotics, Hansen Medical, and Verb Surgical that have become part of larger organizations.
For hospitals, investors, suppliers, and businesses evaluating Surgical Robots companies, important comparison factors include clinical applications, installed systems, regulatory approvals, procedure volumes, system price, recurring instrument costs, service requirements, surgeon training, imaging integration, AI capabilities, surgical accuracy, hospital workflow integration, and long-term total cost of ownership. As robotic assistance spreads into additional specialties, competition is expected to increasingly center on clinical value, accessibility, system flexibility, and the ability to integrate robotics into connected digital operating rooms.